FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine

FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine

Submitted by admin on October 20, 2014 - 10:10am
Source: 
Yahoo
News Tags: 
FDA
Sanofi Pasteur
pediatric hexavalent vaccine
Merck
vaccines
diphtheria
tetanus
pertussis
Hib
hepatitis B
Headline: 
FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine

Do Not Allow Advertisers to Use My Personal information